Promoting safe use of medications: Providing medication education to seniors receiving Meals on Wheels by Ward, Kristina E. & Cohen, Lisa B.
University of Rhode Island
DigitalCommons@URI
Pharmacy Practice Faculty Publications Pharmacy Practice
2015
Promoting safe use of medications: Providing
medication education to seniors receiving Meals on
Wheels
Kristina E. Ward
University of Rhode Island, kward@uri.edu
Lisa B. Cohen
University of Rhode Island, lisacohen@uri.edu
Follow this and additional works at: https://digitalcommons.uri.edu/php_facpubs
The University of Rhode Island Faculty have made this article openly available.
Please let us know how Open Access to this research benefits you.
This is a pre-publication author manuscript of the final, published article.
Terms of Use
This article is made available under the terms and conditions applicable towards Open Access Policy
Articles, as set forth in our Terms of Use.
This Article is brought to you for free and open access by the Pharmacy Practice at DigitalCommons@URI. It has been accepted for inclusion in
Pharmacy Practice Faculty Publications by an authorized administrator of DigitalCommons@URI. For more information, please contact
digitalcommons@etal.uri.edu.
Citation/Publisher Attribution
Ward, K. E., & Cohen, L. B. (2015). Promoting safe use of medications: Providing medication education to seniors receiving Meals on
Wheels. The Consultant Pharmacist, 30(10), 616-622. doi: 10.4140/TCP.n.2015.616
Available at: http://www.dx.doi.org/10.4140/TCP.n.2015.616
Title: 
Promoting safe use of medications: Providing medication education to seniors receiving Meals on 
Wheels 
 
Author Identification: 
Kristina E. Ward, PharmD1* 
Lisa B. Cohen, PharmD1 
 
University of Rhode Island, Department of Pharmacy Practice1 
 
*Corresponding Author: 
 
Kristina E. Ward, PharmD, BCPS 
Clinical Associate Professor of Pharmacy 
University of Rhode Island College of Pharmacy 
7 Greenhouse Road, 295J 
Kingston, RI 02881 
kward@uri.edu  
 
Lisa B. Cohen, PharmD, CDOE 
Associate Professor of Pharmacy 
University of Rhode Island College of Pharmacy 
7 Greenhouse Road, 244D 
Kingston, RI 02881 
lisacohen@uri.edu 
 
Key words: Geriatric, Meals on Wheels, Medication adherence, Medication-related harm, 
Medication safety, Patient counseling 
Abbreviations:  MAR = Medication adherence ratio, MOW = Means on Wheels, OTC = Over-the-
counter. 
Disclosure: This work was funded by a grant from the Food and Drug Administration under the 
Novel Interventions and Collaborations to Improve the Safe Use of Medications (U01) program. 
  
Promoting safe use of medications: Providing medication education to seniors receiving Meals on Wheels 
 
Abstract: 
 
Study Objectives:  To assess whether pharmacist-provided medication education and counseling to 
Meals on Wheels (MOW) participants decreases medication-related preventable harm and improves 
adherence. 
 
Design:  Prospective, quasi-experiment. 
 
Setting: Ambulatory congregrate dining centers. PATIENTS: Persons 60 years of age and older 
participating in MOW receiving prescription, nonprescription, or complementary products were 
eligible. In total, 42 patients consented.  Five patients did not complete the first visit, and 13 patients 
did not complete the six-month follow-up visit. INTERVENTIONS:  Pharmacists provided 
comprehensive medication education about prescription, nonprescription, and complementary 
products at baseline. Additional resources to enhance adherence and avoid medication-related 
preventable harm were provided and discussed. 
 
Main Outcome Measures: Medication-related preventable harm and medication adherence were 
assessed before pharmacist intervention and six months after intervention. Adherence was assessed 
and compared with baseline using the Morisky scale and pill counts. 
 
Results: Women constituted the majority of participants (94.4%) with an average age of 74.5 ± 8.2 
years. Mean difference in Morisky score from baseline to six months was 0.28 (-0.11 to 0.56). After 
adjustment for age and living situation, the change in Morisky score was associated with a 14% 
improvement in adherence. Mean differences in drug-drug and drug-supplement interactions, and 
medication-related harm were not significantly reduced from baseline to study end.  
 
Conclusion: Pharmacist intervention with MOW participants appeared to improve medication 
adherence rates but had limited effect on medication-related preventable harm. 
No findings reached statistical significance as the sample size was inadequate. Larger studies are 
needed to confirm these findings. 
 
Consult Pharm 2015;30:616-22. Doi:10.4140/TCP.n.2015.616 
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Introduction 
 
Drug-related morbidity and mortality is common, with an estimated 100,000 deaths annually and a 
quarter of drug-related injuries being preventable.1 When the Institute of Medicine released To Err Is 
Human: Building a Safer Health System, a much-needed focus was placed on patient safety within 
the United States health care system. The initial focus after publication was on medication errors in a 
hospital setting; however, medication errors cause 1 of every 854 deaths in a hospital as opposed to 
1 of every 131 deaths in the outpatient setting.2 The starkly higher risk of death from a medication 
error in the outpatient setting clearly indicates the need for preventing harm from medications in the 
ambulatory population. 
 
Medication-related preventable harm occurs for a variety of reasons. Medication errors are usually 
multifactorial in origin and are more likely to occur in patients receiving multiple medications.3 
Seniors are more likely to suffer medication-related problems because of their chronic conditions and 
polypharmacy. Polypharmacy has important health consequences because adherence becomes 
more difficult, and the risk for adverse drug reactions, cognitive impairment, falls, and mortality 
increases with increasing numbers of medications while activities of daily living decline.4-10  Previous 
research indicates that inappropriate medication use occurs in 12% to 40% of seniors living in the 
community and that inappropriate use increases as the number of medications used increases.11,12 
Additionally, up to 30% of hospital admissions are caused by drug- related problems or side effects 
of medications.13 
 
While many strategies are available to improve the safe and effective use of drugs, collaboration 
among organizations that already have established trust and reliability among seniors, such as 
Meals on Wheels (MOW), may help pharmacists position themselves to enhance patient education 
and reduce medication misadventures. Because MOW services seniors, a population at high risk for 
preventable harm from medications, we hypothesized that pharmacist- provided medication 
education and counseling to MOW participants would decrease medication-related preventable harm 
and improve adherence. 
 
Methodology 
 
The study was a prospective, open-label, quasi-experiment designed to evaluate whether medication 
education and counseling provided to seniors receiving MOW would decrease preventable harm from 
medications and improve medication adherence. MOW is provided in two ways in Rhode Island: 1) 
delivered to the seniors at home or 2) delivered to a congregate dining site, usually a community 
senior center. To maximize the potential number of participants, presentations about the study were 
made at congregate dining sites for MOW throughout the state to recruit study participants. 
 
Any person older than 60 years of age receiving MOW, also taking prescription, nonprescription, or 
complementary products, was eligible to participate. Interested and eligible participants provided 
informed consent as required by The University of Rhode Island Institutional Review Board. At the 
baseline and six month visits, participants were instructed to bring all their prescription medications, 
over-the-counter (OTC) medications, and complementary products. 
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Adherence to medications for chronic conditions (defined as conditions that persist three months or 
more) was assessed using the Morisky scale and pill counts.14  The Morisky scale is a four-question 
binary response questionnaire that is reported as a scale from 0 (adherent) to 4 (nonadherent).15 Pill 
counts were performed at baseline and six months for each medication used to treat a chronic 
condition; dates of prescription filling and the number of days supply were also recorded. Medication 
adherence ratio (MAR) was used to calculate adherence. MAR is a ratio of the number of pills 
absent in a given time period and the total number of pills prescribed (received) in a given time 
period, which is then multiplied by 100 to convert to percentage.16 Patients were dichotomized to 
adherent or nonadherent based on attainment of 80% adherence or better.16 
 
A comprehensive review of the participant’s medication list (i.e., prescription, nonprescription, 
and dietary supplements), pertinent medical history, and other health information was performed 
to ascertain sources of potentially preventable harm. Preventable harm was defined as an 
adverse drug event (an injury resulting from medical intervention related to a drug) arising from a 
medication error (i.e., errors of prescribing, omission, wrong time, unauthorized drug, improper 
dose, wrong dosage form, wrong drug preparation, wrong administration technique, deteriorated 
drug, monitoring, or compliance).17,18 Presence of preventable harm was assessed using the 
Beers list of medications to quantify and characterize potentially inappropriate medication use, 
proprietary drug interaction software (Drug Interaction Facts; eAnswers by Facts and 
Comparisons) to quantify drug-drug and drug-dietary supplement interactions, and participant 
interview.19 Identification of any medication error or drug interaction (with a significance rating of 
1 or 2, which corresponds to major or moderate severity), prompted a study pharmacist to 
contact the prescriber. 
 
Medication education and counseling were performed by both the study investigators and advanced 
pharmacy practice students in their fourth professional year. The Teach-Back Method and Indian 
Health Service interactive counseling techniques were used.20  Since many patients had less than 
high school education, pictures, colors of medications, and other techniques were used to enhance 
patient education. Patients were allotted approximately an hour to review medications—
nonprescription, prescription, and dietary supplements. Often patients would ask for additional 
information, and students or study pharmacists would follow up with pamphlets, medication 
information, or disease-state information. 
 
Because a large number of medication errors identified on hospital admission originate in 
medication histories, the use of a pocket card may minimize medication histories as a potential 
source of harm.21  Therefore, along with medication education, patients were provided with a 
pocket card to list all medications, including prescription and nonprescription, and dietary 
supplements as well as their doses and frequencies. The pharmacist completed the pocket card 
based on the medication vials provided (for prescription products) and by participant report (for 
nonprescription products and dietary supplements) during the study visits. Pill boxes capable of 
organizing 28 days of medications (divided by day and week) were provided at the initial study 
visit. The pharmacist discussed with each participant how to use the pill box. A medication alarm 
clock (MedCenter 4 Alarm Talking Reminder Clock) was also provided to each participant. The 
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medication alarm clock was programmed during the study visits to alarm at the times of day when 
medications were scheduled for administration, up to four alarms per day. 
 
Statistical Analysis 
 
Because this was a pilot study, 100 participants were targeted for inclusion, which allowed for a 
20% attrition rate. Based on recent work in a similar population, the baseline adherence rate was 
expected to be 66% ± 14%.22 We assumed an improvement of 0% if the intervention did not occur, 
as adherence is not expected to improve or decline in the absence of intervention. Setting alpha at 
0.05 and beta at 0.2, the resultant power would be 80% to detect a change in the adherence rate 
of 9.5% or greater from baseline, with a 15% standard deviation. 
 
Student’s t-tests were used to compare normally distributed continuous data. Wilcoxon-signed rank 
tests were used to examine the differences in the Morisky scores from baseline to six-month 
follow-up. Categorical data were analyzed using 2 or Fisher’s exact test. Medication adherence 
was also assessed using Morisky scale change as improvement in adherence (decreased Morisky 
score) or no change or decreased adherence (increased Morisky score). 
 
Results 
 
In total, 42 patients gave their consent, 5 patients never completed the initial visit, 1 patient died 
after initial visit, and 12 patients did not complete the six-month follow-up visit. Of the patients who 
completed the initial visit, most (94.4%) were women, with an average age of 74.5 ± 8.2 years. The 
congregate sites were located in underserved minority population areas in Providence, Rhode 
Island; 88.6% were nonwhite and 37.1% had less than a high school education. Most patients lived 
alone (68.6%), managed medications on their own (91.4%), ordered refills on their own (88.6%), 
and used 7.9 ± 2.9 chronic medications. Combined never-users or former users of tobacco 
comprised the majority of study patients. A small number of participants reported current alcohol 
use. Additional baseline characteristics are shown in Table 1. 
 
Morisky scores (a score of “0” is adherent, a score of “4” is nonadherent) were calculated at the 
initial visit and the six-month follow-up visit. Morisky scores were ranked according to low/high 
adherence (score of “0”), medium adherence (score of “1” or “2”), or low adherence (score of “3” or 
“4”). At baseline, Morisky score of high adherence was 42.8%, medium adherence was 51.4%, and 
low adherence was 5.8%. At the six-month follow-up visit, scores for the high adherence improved 
to 52.2%, while medium adherence was 43.4%, and low adherence was 4.3%. Wilcoxon-signed 
rank test showed P = 0.317, an insignificant change, although trended improvement. Adherence as 
measured by pill counts at the initial visit was 68.5 ± 42.4%, compared with pill counts at six-month 
follow-up of 87.9 ± 67.5% with a nonsignificant mean difference of 19.5% (95% confidence interval 
[CI] -34.5% to 68.6%; P = 0.92). 
 
The mean difference from baseline in drug-drug interactions and drug-supplement interactions 
determined by the pharmacists and pharmacy students was reduced by 0.11 (95% CI -0.18 to 
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0.40; P = 0.43) and 0.06 (95% CI -0.06 to 0.17; P = 0.33), respectively. Medication-related 
preventable harm had a nonstatistically significant decreased mean difference of 0.06 (95% CI -
0.34 to 0.46). (Table 2) 
 
Discussion 
 
A classification scheme for medication errors is available; however, all potential sources of 
preventable harm when medications are used in the ambulatory population are not addressed.17 
While initiatives to target causes of medication errors such as prescribing (e.g., computerized 
prescriber order entry) and dispensing (e.g., robots, dispensing machines) are ongoing, potentially 
preventable medication-related harm arising from inappropriate or incorrect medication use by 
patients has been more difficult to address. 
 
Adherence to prescribed medication regimens continues to pose challenges. Medication adherence 
diminishes over time and with increasing numbers of prescribed medications.22,24 Seniors are at risk 
for nonadherence and medication-related preventable harm because many are prescribed multiple 
medications based on the presence of chronic diseases; community-dwelling seniors take be- tween 
two and nine prescription medications.4 
 
Although pharmacists have the legal duty to offer medication counseling at the time of dispensing, 
barriers exist. First, participants receiving MOW services have limited access to transportation. As a 
result, interactions with the pharmacy usually occur with the participant caregiver and conveyance of 
information provided by the pharmacist may not be reliable. Some participants may take advantage 
of home delivery or mailing of medications, which also prevents face-to-face interaction with a 
pharmacist. Second, a brief medication information sheet is provided with dispensing that discusses 
how to take the medication, common side effects, and potential adverse effects that require 
immediate follow-up with a health care provider. The most commonly used pharmacy database to 
provide written summaries uses a sixth- to eighth-grade reading level. However, label 
comprehension studies required by the Food and Drug Administration for manufacturers of OTC 
products request a target of fourth- to fifth-grade reading level.25 Third, seniors may have difficulty 
reading the written summaries and prescription vials because of the small font used and visual 
problems. Finally, inadequate health literacy is common in the general and Medicare populations, 
making education about medications challenging.26,27 Our study attempted to address these barriers 
by having face- to-face interaction with participants to directly convey information about medications 
and providing medication education verbally rather than in written form to avoid difficulties with 
varying reading levels. The medication alarm clocks had large print numbers; however, we were 
otherwise unable to address visual barriers. We attempted to provide medication education to 
participants of all health-literacy levels; however, we did not formally assess health literacy. 
 
Persistence of medication adherence is improved with pharmacist intervention. One study 
showed a difference of almost 25%; 69.1% vs. 95.5% of patients achieved persistence of 
adherence in the usual-care group and the pharmacist-care group, respectively; (P < 0.001).22 
In another randomized, controlled study of an ambulatory population, medication adherence 
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was greater in the pharmacist-intervention group after nine months.28  However, the effect 
dissipated after cessation of the pharmacist intervention, suggesting a continued need for 
reinforcement to maintain high levels of medication adherence. 
 
The current study looked at the effect of comprehensive medication education and counseling on 
medication- related preventable harm and adherence to prescribed medications for chronic 
conditions. The study differs from other studies because participants in a MOW program were 
specifically targeted for pharmacist intervention to assess medication-related preventable harm and 
medication adherence. Other studies have evaluated medication education to seniors in assisted 
living facilities; however, medication adherence and preventable medication-related harm were not 
the primary study objectives.29-31 In the current study, the enrolled population was nonwhite women 
who lived alone, managed their own medications, and ordered their own refills, which could present 
opportunities for difficulties with medication adherence and preventable harm. However, alcohol 
use, a potential indicator for unreliability, was low. Former smokers and those who never smoked 
represented the majority of the population, which might suggest a population with a strong interest 
in their health. A number of patients at our congregate sites had no relationship with their 
pharmacist and felt that their providers were more equipped to provide medication information and 
education. Our interactions at the congregate sites with the patients will hopefully improve the 
likelihood that they would seek a relationship with their local pharmacist. 
 
The primary study limitation was the investigators’ inability to recruit enough study participants to 
meet sample size requirements. This occurred because of an unanticipated cessation of MOW 
service to adult day care programs in Rhode Island, which limited the number of potential eligible 
participants. As a result, the sample size was inadequate to detect differences in baseline and 
endpoint Morisky scores assessing medication adherence, differences in pill counts for adherence, or 
medication- related preventable harm. 
 
Conclusion 
 
Although not statistically significant, pharmacist intervention with MOW participants appeared to 
improve medica- tion adherence rates, but had limited effect on medication- related preventable 
harm; larger studies with adequate sample size are needed to confirm these findings. 
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Table 1. Baseline Characteristics 
Characteristics Value (Mean ± SD or %) 
Age in years (n = 35) 74.5 ± 8.2 
Gender (n = 36) 
Female 
Male 
 
34 (94.4%) 
2 (5.6%) 
Race (n = 35) 
White 
Black/African American 
Hispanic 
Asian/Pacific Islander 
Other 
 
4 (11.4%) 
18 (51.4%) 
5 (14.3%) 
4 (11.4%) 
4 (11.4%) 
Highest education level (n = 35) 
Less than high school 
High school Some 
college 
Associate’s 
degree Bachelor’s 
degree Advanced 
degree
 
13 (37.1%) 
13 (37.1%) 
4 (11.4%) 
1 (2.9%) 
3 (8.6%) 
1 (2.9%) 
Smoking history (n = 35) 
Never smoked 
Former smoker 
Current smoker 
 
11 (32.4%) 
19 (55.9%) 
4 (11.8%) 
Alcohol use (n = 35) 
Never 
Past alcohol use 
Present alcohol 
use Illicit drug use 
 
22 (62.9%) 
9 (25.7%) 
4 (11.4%) 
1 (2.9%) 
Housing (n = 35) 
Lives alone 
Lives with spouse/significant other 
Lives with children 
Lives with other, nonrelative 
 
24 (68.6%) 
0 
9 (25.7%) 
2 (5.7%) 
System for refills; yes/no (n = 35) 
Orders on own 
Child assists 
Paid caregiver assists 
25 (71.4%) 
31 (88.6%) 
2 (5.7%) 
2 (5.7%) 
Method of managing medications (n = 35) 
Take from vials 
Use pill box 
Reminder 
system 
 
12 (34.3%) 
20 (57.1%) 
3 (8.6%) 
Abbreviation: SD = Standard deviation.  
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Table 2. Intervention Results 
Value Initial Visit 
(Mean ± SD) 
Six-Month 
Follow-Up 
Mean Difference 
(95% CI) 
P-value 
Morisky scorea 0.91 ± 0.81 0.68 ± 0.89 0.28 
(-0.11 to 0.56) 
0.17 
Drug-drug 
interactions, mean 
0.22 ± 0.55 0.11 ± 0.32 0.11 
(-0.18 to 0.40) 
0.43 
Drug-supplement 
interactions, mean 
0.11 ± 0.32 0.06 ± 0.24 0.06 
(-0.06 to 0.17) 
0.33 
Beers criteria 
medications, mean 
0.28 ± 0.58 0.28 ± 0.58 0.00 
(-0.17 to 0.17) 
1.00 
Medication-related 
preventable harm,b 
mean 
0.50 ± 0.79 0.44 ± 0.71 0.06 
(-0.34 to 0.46) 
0.77 
a Morisky scale is reported as a scale from 0 (adherent) to 4 (nonadherent).15 
b Medication-related preventable harm was calculated by adding significant drug-drug interactions, Beers criteria 
medications, and medication errors identified during participant interview. 
Abbreviation: CI = Confidence interval, SD = Standard deviation. 
 
